英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

coaxial    音标拼音: [k'o'æksiəl]

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Eye Injections for Retinal Diseases | EYLEA® (aflibercept) Injection
    Injections into the eye with EYLEA HD or EYLEA can result in an infection in the eye, retinal detachment (separation of retina from back of the eye) and, more rarely, serious inflammation of blood vessels in the retina that may include blockage treatment with EYLEA will need extended periods of ROP monitoring There is a potential but rare
  • Eylea Injection Treatment for Wet Macular Degeneration
    Regeneron Pharmaceuticals announced that the FDA has approved its Eylea injection treatment for wet age-related macular degeneration (AMD) The treatment, known in the scientific literature as VEGF Trap-Eye, was approved at a recommended dose of 2 mg every four weeks for the first twelve weeks, followed by 2 mg dose every two months (1 2)
  • EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of . . .
    Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA ® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection 2 mg that were maintained with fewer injections First and only treatment approved in wAMD and DME for immediate dosing at 8-week and up to 16-week intervals following three initial monthly doses
  • FACT SHEET ABOUT EYLEA (aflibercept) INJECTION
    aflibercept As with all medications, EYLEA can cause side effects Injection into the eye can result in an infection in the eye and retinal detachment Inflammation in the eye has been reported with the use of EYLEA In some patients, injections with EYLEA may trigger a temporary increase in eye pressure within 1 hour of the injection
  • What Is Eylea? - American Academy of Ophthalmology
    What happens during Eylea treatment? During an outpatient procedure, your ophthalmologist first numbs the eye to block pain Then your doctor injects the Eylea directly into your eye Before the procedure, your ophthalmologist will clean your eye to prevent infection and numb your eye with medicine A very thin needle is passed through the
  • New Product Applications: Lengthening the Time Between Treatments
    Regeneron’s Eylea HD (aflibercept) injection 8 mg allows patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR) to receive less frequent treatment injections after their initial monthly doses than its predecessor, Eylea (aflibercept) injection 2 mg, while still experiencing similar visual gains and anatomic improvements with the
  • FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval
    Regeneron eyes broader flexibility Despite this setback, Regeneron is not hitting any further pause on its blockbuster EYLEA HD The company has already submitted another sBLA, aiming to move the drug into retinal vein occlusion (RVO treatment) This filing seeks: Approval for EYLEA HD to treat macular edema RVO
  • Eylea Patient Tips: 7 things you should know - Drugs. com
    Eylea or Eyela HD treatment for Wet AMD may involve fewer eye injections per year compared to other Wet AMD treatments Eylea is usually injected every 4 or 8 weeks depending upon your condition, but some patients may be able to have injections every 12 weeks after 1 year of treatment
  • FDA Approves Eylea HD, a High-Dose Treatment for Wet AMD That Promises . . .
    The 8 mg product, named Eylea HD, and the 2 mg dose Eylea were developed jointly by Regeneron Pharmaceuticals and Bayer AG; the new drug earned priority review status from the FDA on the basis of
  • Regeneron reveals positive results from multiple trials evaluating . . .
    However, the current treatment paradigm of monthly eye injections can make it challenging for patients to maintain their treatment plan, potentially leading to poor adherence and vision loss,” said Hariprasad EYLEA HD (known as Eylea 8 mg in the European Union and Japan) is being jointly developed by Regeneron and Bayer AG References





中文字典-英文字典  2005-2009